Population pharmacokinetics of lopinavir/ritonavir (LPVr) in HIV-1-infected patients

被引：0
|
作者：
Crommentuyn, KML
Kappelhoff, BS
Mulder, JW
Mairuhu, ATA
van Gorp, ECM
Meenhorst, PL
Huitema, ADR
Beijnen, JH
机构：
[1] Slotervaart Hosp, Dept Pharm & Pharmacol, Amsterdam, Netherlands
[2] Slotervaart Hosp, Dept Internal Med, Amsterdam, Netherlands
[3] Univ Utrecht, Fac Pharmaceut Sci, Dept Biomed Anal, Div Drug Toxicol, Utrecht, Netherlands
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2005年 / 59卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：609 / 610
页数：2
相关论文
共 50 条
  • [41] Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children
    Rudin, Christoph
    Wolbers, Marcel
    Nadal, David
    Rickenbach, Martin
    Bucher, Heiner C.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2010, 95 (06) : 478 - 481
  • [42] Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals
    De Maat, MMR
    Huitema, ADR
    Mulder, JW
    Meenhorst, PL
    Van Gorp, ECM
    Beijnen, JH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (05) : 552P - 552P
  • [43] Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals
    David J. Back
    Andrew Owen
    Saye H. Khoo
    Clinical Pharmacokinetics, 2006, 45 : 213 - 214
  • [44] Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals
    Kappelhoff, BS
    Huitema, ADR
    Yalvaç, Z
    Prins, JM
    Mulder, JW
    Meenhorst, PL
    Beijnen, JH
    CLINICAL PHARMACOKINETICS, 2005, 44 (08) : 849 - 861
  • [45] Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals
    Bregt S. Kappelhoff
    Alwin D. R. Huitema
    Zeynep Yalvaç
    Jan M. Prins
    Jan W. Mulder
    Pieter L. Meenhorst
    Jos H. Beijnen
    Clinical Pharmacokinetics, 2005, 44 : 849 - 861
  • [46] Lopinavir population pharmacokinetics on HIV-infected pregnant women
    Bouillon-Pichault, M.
    Treluyer, J. M.
    Rey, E.
    Pons, G.
    Jullien, V.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 23 - 23
  • [47] Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals
    Kappelhoff, BS
    Huitema, ADR
    Yalvaç, Z
    Prins, JM
    Beijnen, JH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (04) : 467 - 467
  • [48] Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals
    Aouri, Manel
    Barcelo, Catalina
    Guidi, Monia
    Rotger, Margalida
    Cavassini, Matthias
    Hizrel, Cedric
    Buclin, Thierry
    Decosterd, Laurent A.
    Csajka, Chantal
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (01)
  • [49] Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals
    de Maat, MMR
    Huitema, ADR
    Mulder, JW
    Meenhorst, PL
    van Gorp, ECM
    Beijnen, JH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (04) : 378 - 385
  • [50] Population Pharmacokinetics of Nevirapine in HIV-1-Infected Pregnant Women and Their Neonates
    Benaboud, Sihem
    Ekouevi, Didier K.
    Urien, Saik
    Rey, Elisabeth
    Arrive, Elise
    Blanche, Stephane
    Gray, Glenda
    Sim, Kruy Leang
    Avit, Divine
    McIntyre, James
    Nerrienet, Eric
    Dabis, Francois
    Treluyer, Jean-Marc
    Hirt, Deborah
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (01) : 331 - 337
12345